Pedigree Sample Clauses

Pedigree. In the passage of the Drug Quality and Security Act (H.R. 3204) on November 27, 2013, Title II of the Act, establishes a national system for tracing pharmaceutical products through the supply chain and sets national licensing standards for wholesale distributors. This legislation preempts the current state pedigree and serialization laws, however, as the Drug Quality and Security Act transitions, the Federal pedigree requirements within the Prescription Drug Marketing Act (PDMA) are to remain in effect for the immediate future. The Wholesaler is required to comply with all aspects of Drug Quality and Security Act as it transitions, and until January 1, 2015, to continue to comply with PDMA. During the interim period, from DSCSA being passed, 11/27/13, until 1/1/15, the current federal minimum standards for the wholesale distribution of prescription drugs apply, meaning PDMA remains in effect and can be enforced. Cardinal Health is an Authorized Distributor of Record for all prescription drugs distributed and is therefore not required to pass pedigree under PDMA. If any new transitions of the Drug Quality and Security Act which require change(s) to the current pharmaceutical distribution procedure(s), a minimum of 30 calendar days’ notice of the change(s) will be provided so MMCAP Participating Facilities can prepare. Wholesaler agrees to provide next day service for those Products requiring a Pedigree. As the Drug Quality and Security Act, Title II is a requirement upon wholesalers as a national licensing standard, Wholesaler will not charge any fees throughout the term of this Contract and any extensions to MMCAP or MMCAP Participating Facilities related to complying with this Act. As part of the quarterly executive business review with MMCAP, the Wholesaler will be required to provide updates on the Drug Quality and Security Act, Title II transition and how the Wholesaler is integrating compliance aspects into its work deliverables to MMCAP Participating Facilities and MMCAP.

Pedigree. Vendor guarantees that all Products purchased are sourced directly from the manufacturer or the manufacturer’s authorized distributor, without exception. Vendor agrees that its business practices meet or exceed each MMCAP Member’s Pedigree requirements that it services. Vendor will adhere to any future changes in Pedigree laws for all applicable MMCAP Member States. If any new Pedigree laws which require change(s) to the current pharmaceutical distribution procedure(s) are passed, a minimum of 30 calendar days’ notice of the change(s) will be provided so MMCAP Participating Facilities can prepare. Vendor agrees to provide next day service for those Products requiring a Pedigree. All fees associated with providing Pedigrees are listed on Attachment B, Discounts and Fees.

Pedigree. A record containing information regarding each transaction resulting in a change of ownership of a given medication, from sale by a manufacturer, through acquisition and sale by one or more wholesalers, manufacturers, or pharmacies, until final sale to a pharmacy or other person furnishing, administering, or dispensing the medication. Pharmaceutical Prime Vendor (PPV) - Also referred to as Vendor or Prime Vendor, is a business that functions as a purchaser’s source of distribution for a wide array of pharmaceutical and related Products as Product(s) - Synonymously used to denote the merchandise requested by the MMCAP Participating Facilities to be delivered through the Vendor.